Finance

Beta
Lists
SHRX:CVE
Sharp Therapeutics Corp
CA$2.10
0.00%
(0.00) 1D
Apr 17, 10:51:49 AM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SHRX...
Mkt. cap
63.04M
Avg. vol.
0.00
Volume
0.00
52-wk high
CA$5.00
52-wk low
CA$0.23
EPS
-CA$0.29
Mkt. cap
63.04M
Avg. vol.
0.00
Volume
0.00
52-wk high
CA$5.00
52-wk low
CA$0.23
EPS
-CA$0.29
News stories
From sources across the web
About Sharp Therapeutics Corp
CEO-
Employees-
Founded2021
HeadquartersPittsburgh, Pennsylvania, United States
SectorPharmaceutical industry
Websitesharptx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
891.00K
977.94K
684.43K
975.47K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
398.40K
423.89K
319.91K
589.04K
Operating expense
1.32M
1.43M
1.04M
1.72M
Total operating expenses
1.32M
1.43M
1.04M
1.72M
Operating income
-1.32M
-1.43M
-1.04M
-1.72M
Other non operating income
-1.89M
2.04M
-6.86K
-632.12K
EBT including unusual items
-3.25M
559.10K
-1.09M
-2.39M
EBT excluding unusual items
-3.25M
559.10K
-1.09M
-2.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.25M
559.10K
-1.09M
-2.39M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
82.00
Interest expense
-42.13K
-41.87K
-41.61K
-41.28K
Net interest expenses
-42.13K
-41.87K
-41.61K
-41.20K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.32M
-1.43M
-1.03M
-1.72M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer